Charles River Laboratories International (CRL) Operating Margin (2009 - 2026)
Charles River Laboratories International (CRL) operating margin from Jun 27, 2009 to Mar 28, 2026. The current Charles River Laboratories International (CRL) operating margin is 12.04%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Charles River Laboratories International (CRL)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 0.63% | -88.84% |
| 2024 | 5.61% | -62.45% |
| 2023 | 14.95% | -8.70% |
| 2022 | 16.37% | -1.74% |
| 2021 | 16.66% | +12.58% |
| 2020 | 14.80% | +10.47% |
| 2019 | 13.40% | -3.58% |
| 2019 | 13.89% | +14.53% |
| 2019 | 12.13% | +5.09% |
| 2019 | 11.54% | -21.06% |
| 2018 | 14.62% | +1.46% |
| 2018 | 14.41% | +9.97% |
| 2018 | 13.11% | -4.56% |
| 2018 | 13.73% | -11.52% |
| 2017 | 15.52% | -2.72% |
| 2017 | 15.95% | -8.38% |
| 2017 | 17.41% | +11.35% |
| 2017 | 15.64% | +10.69% |
| 2016 | 14.13% | +2.29% |
| 2016 | 13.81% | +3.26% |
| 2016 | 13.38% | -7.78% |
| 2016 | 14.50% | -4.22% |
| 2015 | 15.14% | -4.54% |
| 2015 | 15.86% | -3.36% |
| 2015 | 16.41% | +22.29% |
| 2015 | 13.42% | -1.96% |
| 2014 | 13.69% | -2.86% |
| 2014 | 14.09% | -5.76% |
| 2014 | 14.96% | +12.76% |
| 2014 | 13.26% | +2.11% |
| 2013 | 12.99% | -7.08% |
| 2013 | 13.98% | -5.18% |
| 2013 | 14.74% | +0.42% |
| 2013 | 14.68% | +0.04% |
| 2012 | 14.68% | -3.79% |
| 2011 | 15.25% | -157.92% |
| 2010 | -26.34% | -281.93% |
| 2009 | 14.48% | -141.50% |
| 2008 | -34.88% | N/A |
Comparison Charles River Laboratories International (CRL) operating margin with competitors
Charles River Laboratories International (CRL) operating margin is 12.04%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 31.78% | +163.95% |
| SHC | Sotera Health Company | 28.16% | +133.88% |
| MTD | Mettler-Toledo International Inc | 26.00% | +115.94% |
| DHR | Danaher Corp | 22.58% | +87.54% |
| QGEN | Qiagen NV | 22.29% | +85.13% |
| MEDP | Medpace Holdings Inc | 20.03% | +66.36% |
| A | Agilent Technologies Inc | 19.63% | +63.04% |
| ILMN | Illumina Inc | 19.16% | +59.13% |
| TMO | Thermo Fisher Scientific Inc | 16.93% | +40.61% |
| BLLN | Billiontoone Inc - Class A | 16.45% | +36.63% |
| VCYT | Veracyte Inc | 16.28% | +35.21% |
| DGX | Quest Diagnostics Inc | 13.78% | +14.45% |
| IQV | IQVIA Holdings Inc | 12.38% | +2.82% |
| LH | Laboratory Corp Of America Holdings | 10.76% | -10.63% |
| RVTY | Revvity Inc | 10.67% | -11.38% |
| ICLR | Icon Plc | 5.37% | -55.40% |
| CDNA | Caredx Inc | 1.02% | -91.53% |